Next Article in Journal
Mitochondrial Succinate Metabolism and Reactive Oxygen Species Are Important but Not Essential for Eliciting Carotid Body and Ventilatory Responses to Hypoxia in the Rat
Next Article in Special Issue
Protein Engineering of Electron Transfer Components from Electroactive Geobacter Bacteria
Previous Article in Journal
Molybdenum-Induced Regulation of Antioxidant Defense-Mitigated Cadmium Stress in Aromatic Rice and Improved Crop Growth, Yield, and Quality Traits
Previous Article in Special Issue
Methionine Sulfoxide Reductases Contribute to Anaerobic Fermentative Metabolism in Bacillus cereus
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 10
Issue 6
10.3390/antiox10060839
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

ROS Defense Systems and Terminal Oxidases in Bacteria

by
Vitaliy B. Borisov
1,*,
Sergey A. Siletsky
1,
Martina R. Nastasi
2 and
Elena Forte
2,*
1
Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory, 119991 Moscow, Russia
2
Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro, 5, 00185 Rome, Italy
*
Authors to whom correspondence should be addressed.
Antioxidants 2021, 10(6), 839; https://doi.org/10.3390/antiox10060839
Submission received: 26 April 2021 / Revised: 19 May 2021 / Accepted: 21 May 2021 / Published: 24 May 2021
(This article belongs to the Special Issue Redox Biology in Microorganisms)
Browse Figures
Versions Notes

Abstract

:
Reactive oxygen species (ROS) comprise the superoxide anion (O2•−), hydrogen peroxide (H2O2), hydroxyl radical (•OH), and singlet oxygen (1O2). ROS can damage a variety of macromolecules, including DNA, RNA, proteins, and lipids, and compromise cell viability. To prevent or reduce ROS-induced oxidative stress, bacteria utilize different ROS defense mechanisms, of which ROS scavenging enzymes, such as superoxide dismutases, catalases, and peroxidases, are the best characterized. Recently, evidence has been accumulating that some of the terminal oxidases in bacterial respiratory chains may also play a protective role against ROS. The present review covers this role of terminal oxidases in light of recent findings.

Graphical Abstract

1. Introduction

Reactive oxygen species (ROS) are partially reduced oxygen derivatives. They include the superoxide anion (O2•−), hydrogen peroxide (H2O2), hydroxyl radical (•OH), and singlet oxygen (1O2). ROS can be produced within the cell as an unavoidable consequence of bacterial metabolism or derived from the environment. ROS are generated by the host innate immune system in response to bacterial colonization. Invading pathogens are recognized by pattern recognition receptors located on the surface of a phagocyte. As a result, in the course of phagocytosis, the production of ROS and reactive nitrogen species (RNS) is triggered to generate bactericidal oxidative stress [1]. O2•− is generated by the phagocyte NADPH oxidase. O2•− can then undergo dismutation to form H2O2 spontaneously or enzymatically by superoxide dismutase. H2O2 is also generated by many microorganisms at concentrations sufficient to kill their nearby competitors. For instance, arginine-replete Streptococcus gordonii monocultures can maintain H2O2 concentrations within 20–30 μM throughout exponential growth [2]. In exponentially growing Escherichia coli (E. coli) cells, H2O2 production was estimated to occur at rates of 9–22 μM/s using strains lacking intracellular scavenging enzymes and grown on a variety of growth substrates [3]. H2O2 permeates freely across bacterial membranes and can react with Fe2+, producing a very powerful oxidant through this Fenton reaction, •OH. One more extremely dangerous ROS, 1O2, can be generated by endogenous photosensitizers, such as flavins, quinones, porphyrins, and rhodopsins [4]. All these ROS, particularly •OH and 1O2, can damage bacterial DNA, RNA, proteins, and lipids. To protect themselves against ROS-induced oxidative stress, bacteria utilize different ROS defense mechanisms, of which the enzymatic ROS scavengers, such as superoxide dismutases, catalases, and peroxidases are the best characterized [1,5]. Superoxide dismutases catalyze the dismutation of 2O2•− into H2O2 and O2 with the participation of 2H+ as co-substrate. The decomposition of H2O2 is usually conducted by catalases or peroxidases. Catalases catalyze the disproportionation of 2H2O2 into 2H2O and O2. Peroxidases catalyze the reduction of H2O2 (and/or organic hydroperoxides) by a wide variety of organic and inorganic substrates that serve as electron donor. In the case of E. coli, the most studied species of bacteria, the following enzymes are used to degrade H2O2 in vivo: the KatG and KatE catalases [6], the NADH peroxidase AhpCF [7], and the periplasmic cytochrome c peroxidase YhjA (also denoted as Ccp) that possesses quinol peroxidase activity [8,9].
Recently, evidence has been accumulated indicating that some of the enzymatic complexes of the terminal segment of the O2-dependent respiratory chains, terminal oxidases, may also contribute to ROS defense mechanisms in bacteria. These enzymes catalyze the four-electron reduction of O2 to 2H2O using quinol or cytochrome c as the electron donor [10,11,12,13,14,15]. The membrane-embedded terminal oxidases include the superfamily of heme-copper oxidases [13,14,16,17,18,19,20,21,22,23,24] and the family of copper-lacking bd-type oxidases (cytochrome bd) [11,25,26,27,28,29]. All these oxidases couple the catalytic redox reaction to the generation of a proton motive force [30,31,32]. Unlike cytochrome bd [33,34,35], the heme-copper oxidases create the proton motive force not only due to the transfer of protons and electrons to the catalytic site from different sides of the membrane but also due to a unique mechanism of the proton pumping [36,37]. This is a likely reason why the proton to electron stoichiometry (characteristic of the bioenergetic efficiency) of the heme-copper oxidases is 1.5-2 times higher than that of cytochrome bd [30,38]. Heme-copper oxidases are divided into families A, B and C based on the constituents of their proton channels [39,40,41]. Cytochrome bd, in turn, can be classified into two subfamilies, S and L, based on the size of a hydrophilic region between transmembrane helices 6 and 7 of subunit I, denoted as the Q-loop [42,43]. A heme-copper oxidase usually carries three or four redox centers depending on whether it is a quinol oxidase or cytochrome c oxidase (COX). In addition to the electron entry subunit that carries a binuclear CuA center, some COXs (caa3, cbb3) have an additional domain, the substrate cytochrome c [44,45,46]. A distinctive feature of the heme-copper oxidase superfamily is an active site, called the binuclear center (BNC), which consists of a high-spin heme (a3, b3, or o3) and a copper ion (CuB) close to the heme-iron. In the binuclear center, O2 is reduced to two molecules of H2O. All cytochrome bds known to date are quinol (ubiquinol or menaquinol) oxidases. A typical cytochrome bd has three redox centers, hemes b558, b595, and d but no copper. The high-spin heme d is the site in which the oxygen chemistry takes place. Sometimes heme d is replaced by heme b [47]. Cytochrome bd usually reveals a much higher affinity for O2 than heme-copper oxidases [48,49,50,51].
While the main role of most heme-copper oxidases in microbial metabolism is to conserve energy, cytochrome bd appears to serve other important functions in bacteria [52,53,54,55,56]. The bd-type oxidases were reported to endow bacteria with resistance to nitric oxide (NO) [57,58,59,60,61,62,63,64,65,66], peroxynitrite [53,67], sulfide [68,69,70,71], ammonia [72], cyanide [68,73,74]. This is probably the reason why cytochrome bd is so common in pathogenic bacteria [75]. The absence of these enzymes in eukaryotes makes them very attractive as potential targets for new antibacterial drugs [76,77,78,79,80,81].
In this review, we discuss the contribution of the bd-type oxidases and other terminal oxidases to oxidative stress defense mechanisms in bacteria in light of recent findings.

2. The bd-Type Oxidases by Fast O2 Scavenging Protect O2-Labile Enzymes from Oxidative Inactivation and Reduce Intracellular ROS Levels

Possibly due to the lack of proton-pumping machinery, cytochrome bd generally consumes O2 much more rapidly than heme-copper oxidases. In E. coli and Azotobacter vinelandii, the bimolecular rate constant for O2 reaction with the bd enzyme approaches diffusion control [82]. This trait allows the bd oxidase to play a crucial role in “respiratory protection” of nitrogenase, the O2-labile N2-fixing enzyme complex, even under aerobic conditions [83] (Figure 1). The prevention of O2 inhibition of nitrogenase activity by cytochrome bd was shown in Azorhizobium caulinodans [84], A. vinelandii [83], Klebsiella pneumoniae [85]. This is in agreement with the fact that mutant strains lacking cytochrome bd are not able to fix nitrogen in the air [86]. Due to the presence of the bd enzyme, some bacteria classified as strict anaerobes, e.g., Bacteroides fragilis [87] and Desulfovibrio gigas [88,89], can survive at low O2 concentrations. In this case, apart from protection against the deleterious effects of O2, cytochrome bd provides the bacteria with the proton motive force to drive ATP synthesis and dissipates excess reducing equivalents via the O2-dependent respiratory chain. Consistently, in the anoxygenic phototroph Rubrivivax gelatinosus, the bd oxidase is used to reduce the environmental O2 pressure [90]. This expands the physiological range of ambient O2 tensions for this bacterium under which photosynthesis can be initiated. In E. coli, a facultative anaerobic bacterium, cytochrome bd inhibits the production of intracellular H2O2 by reduced fumarate reductase. This is observed when anaerobic cultures of an E. coli strain devoid of canonical H2O2-scavenging enzymes KatG, KatE, and AhpCF are abruptly aerated [91]. An underlying mechanism for this phenomenon upon aeration is likely the action of cytochrome bd as an electron sink. The bd enzyme pulls electrons away from fumarate reductase via the quinone pool. As a consequence, the rate at which fumarate reductase generates H2O2 decreases [91].

3. Bacterial Mutants Devoid of Cytochrome bd Show Higher Sensitivity to H2O2. Cytochrome bd Expression Increases in the Presence of H2O2

Cytochrome bd plays a role in protecting bacterial cells against oxidative stress caused by H2O2. E. coli mutant cells devoid of cytochrome bd-I (encoded by the cydAB operon) are extremely sensitive to H2O2 exposure [92,93,94]. Consistently, expression of cytochrome bd-I in E. coli K-12 increases in the presence of external H2O2 [94]. In uropathogenic E. coli, the doubling time of strains lacking either cytochrome bd-I or cytochrome bd-II (encoded by the cyxAB operon) increases considerably following treatment with 1 mM H2O2 [66]. Such a protective function of the bd enzyme is not limited to E. coli strains. In the case of A. vinelandii cells, 0.15 mM H2O2 appeared to be more toxic to the mutant strain devoid of the bd oxidase than to the wild-type strain [95]. The mutant strain of the sulfate-reducing bacterium Alishewanella sp. WH16-1, deficient in cytochrome bd, is also more sensitive to H2O2 than the wild type and complemented strain [96]. Similarly, Brucella abortus mutants lacking the bd oxidase activity show higher sensitivity to added H2O2 [97]. This sensitivity is reversed after the introduction of a plasmid (pSEK102) that contains a copy of the cydAB operon. Overexpression of superoxide dismutase and catalase can also alleviate the loss of cytochrome bd [97], emphasizing that the antioxidant properties of these enzymes are of similar importance. In Porphyromonas gingivalis involved in the pathogenesis of periodontitis, the absence of the bd oxidase leads to an increase in the susceptibility of exponentially growing bacteria to 0.5 mM H2O2 [98]. The complementation of the P. gingivalis mutant with the native cydAB genes partially restores the resistance of the cells to H2O2 treatment. Small et al. [99] reported the catalase-independent hyper-resistance to H2O2 in Mycobacterium tuberculosis cells overexpressing the bd enzyme. The hypersensitivity of the cydAB mutants to exogenous H2O2 was also documented for Mycobacterium smegmatis [100]. Consistently, in Staphylococcus aureus, the cydAB genes are strongly (by 8-9-fold) induced upon 20 min of exposure to H2O2 [101]. Altogether, these data suggest that at least in a few bacteria, including pathogenic strains, cytochrome bd contributes to mechanisms that provide bacterial defense against H2O2-induced oxidative damage.

4. Catalase-Like Activity of Cytochrome bd

Apart from the above-described ways by which cytochrome bd can decrease intracellular ROS levels indirectly, the enzyme was reported to be able to metabolize H2O2 directly. Borisov et al. [102] reported that the addition of Н2О2 to the isolated as-prepared cytochrome bd-I from E. coli results in the О2 evolution in a sealed respirometry chamber (Figure 2, main panel). The observed rate of О2 evolution is proportional to the enzyme concentration. The reaction rate also increases linearly with the Н2О2 concentration, up to 0.2–0.5 mM of the reactant. At higher [Н2О2], however, the dependence exhibits somewhat saturation behavior (Figure 2, inset), which may be due to partial inactivation of cytochrome bd-I by ROS. In this reaction, there is the evolution of approximately one О2 molecule per every two Н2О2 molecules decomposed, implying the catalase-like reaction mechanism. A series of experiments show that the reaction is indeed associated with the bd-I enzyme [102]. After the thermal inactivation of cytochrome bd-I, the О2 evolution is no longer detected. Hence, the possible presence of trace amounts of adventitious transition metals cannot be the reason for the observed О2 evolution. The addition of NO, even at a concentration of 20 μM, does not affect the rate of O2 formation. At the same time, NO was reported to inhibit bona fide catalase with Ki of ~0.18 µM [103]. Furthermore, if the bd-I enzyme is reduced completely with dithiothreitol (DTT) and 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone (Q1), the catalase-like activity is lacking. However, if bona fide catalase is then added to the chamber, the О2 evolution resumes. It is hard to imagine that a contaminant catalase, if present, would be redox (DTT/Q1)-sensitive, especially as many catalases are not reducible with as strong a reducing agent as dithionite [104], even in the presence of a mediator [105]. Thus, the latter two findings suggest that the isolated untagged cytochrome bd-I, rather than a potential presence of a native catalase as a contaminant, is responsible for the observed activity. It should be noted that this conclusion is not consistent with the data of Al-Attar et al. [106]. They reported that the isolated His6-tagged cytochrome bd-I of E. coli does not perform a catalase-like activity as the addition of 1 mM Н2О2 to the enzyme does not lead to О2 generation [106]. Al-Attar et al. proposed that the catalase-like activity of cytochrome bd-I shown by Borisov et al. [102] might be due to impurities that include an unknown membrane-associated catalase. However, such an activity is also detected in vivo [102]. Substantial rates of О2 production are observed if H2O2 is added to respiring E. coli UM2 cells devoid of KatE and KatG but overexpressing the bd-I enzyme (Figure 3, red line). If cytochrome bd-I is not overexpressed, the reaction is not seen (Figure 3, blue line). This can only happen if “an unknown membrane-associated catalase” in the cells is cytochrome bd-I. This discrepancy may be attributed to the differences between the protein forms (untagged vs. hexahistidine-tagged) or other experimental conditions used for protein expression and purification that Al-Attar et al. also do not exclude. Additional work is needed to resolve the controversy.
The molecular mechanism underlying the catalase-like activity of cytochrome bd-I remains unclear. To try to identify the enzyme site responsible for the observed reaction, a few compounds targeting different sites were tested [102]. Antimycin A (167 µM), which inhibits the bd-I oxidase via interaction with the quinol binding site [107], does not affect the О2 evolution. Consistently, 250 µM oxidized Q1 also does not inhibit the reaction. Hence, the quinol binding site does not participate in the activity. Similarly, the rate of О2 formation is not affected by 20 µM N-ethylmaleimide, a small organic electrophile that blocks cysteine thiols through covalent modification [108]. This suggests that the enzyme thiol groups are also not involved in the reaction. Neither 20 μM NO nor 2 μM CO inhibits the О2 evolution. The canonical О2 reductase activity of cytochrome bd-I was reported to be blocked by NO and carbon monoxide (CO) with Ki of 100 [57] and 40 nM [109], respectively. Since both NO and CO do this through binding to heme d, the participation of this heme in the catalase-like activity is not very likely. This conclusion is also supported by the fact that the catalase-like and the heme d-based О2 reductase activities do not seem to compete with each other. The reaction is also insensitive to its product, О2, as the rates of О2 evolution at 3 and 255 µM О2 are virtually identical. Notwithstanding this, two small molecules were found to effectively inhibit the catalase-like activity, cyanide and azide. These ligands are known to block heme-containing enzymes by targeting ferric heme-iron. The О2 evolution is inhibited by cyanide with a Ki of 2.5 µM. Consistently, 100 µM azide inhibits the activity almost completely—by 98%. The catalase-like activity appeared to be approximately three orders of magnitude more sensitive to these ligands than the heme d-based О2 reductase one. This indicates that a heme, but not heme d, is involved in the reaction. The site at which the catalase-like chemistry occurs could be heme b595 (Figure 4). It is pentacoordinate high-spin and therefore can potentially bind an external ligand, such as H2O2 [110]. It also cannot be ruled out that this catalytic role is played by heme b558. Although this is a hexacoordinate low-spin heme, the bond between its sixth axial ligand Met393 and the iron ion is weak and can be replaced with a stronger external ligand [111]. Surprisingly, the addition of cyanide to the as-prepared cytochrome bd-I at a concentration (50 µM) that fully inhibits the catalase-like activity induces small absorption changes as if the ligand reacts with only some small population of heme b. If this is the case, only a fraction of the enzyme (2–4%) is involved in the reaction but with an apparent turnover number greater than 3000 s−1 [102]. The catalase-like activity of cytochrome bd-I could be induced in vivo in response to the oxidative stress by post-translational protein modification, proteolysis, protein truncation in the translation process, or interaction of the enzyme with other cellular components.
Preparations of untagged cytochrome bd-II isolated from E. coli also show high catalase-like activity. Similar to cytochrome bd-I, NO at a high concentration (20 µM) does not affect the activity (Figure 5, top panel). The observed О2 evolution is also susceptible to the bd-II enzyme redox-state. When cytochrome bd-II is converted into the fully reduced state following the consumption of all O2 in turnover with excess DTT and Q1, the H2O2-induced catalase-like activity is no longer observed. However, if a bona fide catalase is subsequently added, the reaction proceeds (Figure 5, bottom panel). Further studies will show how this discovered activity of cytochrome bd-II (Figure 4) contributes to the bacterial defense mechanisms against oxidative stress in vivo. In this regard, a very recent report by Chanin et al. [112] on the role of cytochrome bd-II-mediated aerobic respiration of E. coli during intestinal inflammation deserves attention. In the course of the inflammatory process, the host produces antimicrobial products including O2•− to impede bacterial growth. The O2•− molecules generated by the Nox1 NADPH oxidase undergo rapid dismutation to H2O2 and O2 by superoxide dismutase. Using chemical and genetic murine models of noninfectious colitis, Chanin et al. showed that cytochrome bd-II provides a fitness advantage for E. coli during anaerobic growth in the presence of H2O2 in the inflamed murine intestine. In the absence of Nox1, this fitness advantage is ablated. To do this, the bd-II enzyme may use H2O2 or its breakdown product O2 generated by the catalases KatE and KatG, as the substrate. It turned out that in the absence of KatE and KatG, at 5 µM H2O2, the wild-type strain outcompetes the mutant strain devoid of cytochrome bd-II. For this reason, Chanin et al. concluded that O2 produced by catalase-mediated degradation of H2O2 serves as the terminal electron acceptor for the bd-II oxidase [112]. However, given the observed catalase-like activity of cytochrome bd-II (Figure 5, top panel), the possibility that at higher H2O2 concentrations, cytochrome bd-II could also metabolize H2O2 in vivo, contributing to the O2 pool formation in the inflamed gut, cannot be excluded. Whatever the exact mechanism is, detoxification of the host-derived ROS through cytochrome bd-II allows E. coli to respire in an otherwise anaerobic environment, promoting bacterial outgrowth [112].
Reduced catalase-like activity was determined in cell-free extracts of A. vinelandii when comparing the mutant strain MK5 devoid of the bd oxidase and the wild-type strain UW136 [95]. In Alishewanella sp. WH16-1, cytochrome bd is also suggested to catalyze the decomposition of H2O2 via the catalase-like reaction (see Figure 7 in [96]). A dramatic increase in resistance of M. tuberculosis to Н2О2 upon the overexpression of cytochrome bd reported by Small et al. [99] could be explained, at least in part, by the ability of the bd oxidase to perform the catalase-like reaction [113].

5. Peroxidase-Like Activity of Cytochrome bd

Borisov et al. reported [114] that the isolated untagged cytochrome bd-I from E. coli displays a peroxidase-like activity. Under aerobic conditions, the enzyme can catalyze the oxidation of guaiacol (o-methoxyphenol), benzohydroquinone, ferrocene, and ferrocyanide upon the addition of H2O2. Using guaiacol as the electron donor, the effect of a few inhibitors of the O2 reductase activity of cytochrome bd-I on the peroxidase-like activity was studied. It turned out that 2-n-heptyl 4-hydroxyquinoline-N-oxide (HQNO), pentachlorophenol, and cyanide inhibit both activities at similar concentrations [114]. Based on the inhibitory analysis, it was concluded that guaiacol binds and donates electrons to the quinol binding site of cytochrome bd-I. The electrons are then transferred to the heme d site at which H2O2 is bound and reduced to 2H2O. Although an apparent turnover number for the guaiacol peroxidation reaction is as low as about 4 s−1, it was suggested [53] that this value could be much higher in vivo where the natural quinol is used as the electron donor.
Consistent with this, Al-Attar et al. later reported [106] that, under anaerobic conditions, the isolated His6-tagged cytochrome bd-I of E. coli shows significant peroxidase-like activity. As the electron donor, decyl-ubiquinol (dQH2) was used and the oxidation of dQH2 by H2O2 was measured spectrophotometrically by monitoring the absorption change at 260 nm. The average dQH2/H2O2 ratio appeared to be 1.05 ± 0.19, which is consistent with the peroxidase reaction mechanism. The kcat and KM values were reported to be 101 ± 10 s−1 and 6.6 ± 1.1 mM H2O2, respectively. This gives a specificity constant kcat/KM of 1.5 × 104 M−1 s−1 [106]. In contrast to the catalase-like activity, the dQH2 peroxidase reaction is promptly, but reversibly, inhibited by NO (Figure 6). This suggests that the heme d site is directly involved in the binding and reduction of H2O2 (Figure 7). The reaction is also inhibited by HQNO (50% inhibition is measured at about 10-15 μM HQNO), emphasizing that dQH2 injects electrons directly into the quinol binding site of cytochrome bd-I. The observed high rates of the reaction indicate that it may have physiological significance in E. coli.

6. ROS and Heme-Copper Oxidases

The main function of heme-copper respiratory oxidases in mitochondria and most bacteria is highly efficient energy conversion and generation of the membrane potential (the proton motive force) due to the redox energy of O2 reduction to water [115,116]. The unique ability of heme-copper oxidases to pump protons through the membrane determines their distinctive features: the presence of a special device for a redox-coupled proton pump and intra-protein proton-conducting pathways arranged in a special way [37]. Each of the single-electron steps in the catalytic cycle of COX during the O2 reduction in the BNC (heme a3/CuB) is associated with the transfer of ~1 pumped proton through the membrane. The catalytic cycle of heme-copper oxidases is a highly coordinated system of individual electrogenic stages of electron transfer from cytochrome c on the P-side of the membrane and substrate protons on the N-side through the protein matrix to the BNC, as well as the transfer of pumped protons from the N-side of the membrane through temporary loading proton sites to the external water phase [32].
The BNC of COX is designed by nature to avoid, during the reduction of O2, producing of free forms of ROS, which would be released to the bulk phase. After binding of the oxygen molecule to heme a3 in the reduced BNC, the O-O bond is broken and four electrons are transferred to O2 in virtually one step. The heme a3 iron gives up two electrons and is oxidized to an oxidation state of +4, while CuB and the redox-active tyrosine residue give the other two electrons for complete reduction of the oxygen atoms to produce two molecules of water. The resulting PM catalytic intermediate is homologous to compound I of peroxidases. The P0 compound corresponding to compound 0 in horseradish peroxidase with the bound primary H2O2 adduct of the heme moiety was not time-resolved in the case of COX of mitochondria and other heme-copper oxidases of the A family. PM has an oxoferryl state of heme a3 with the oxidized tyrosine residue (the radical form) whose reduction by an electron from cytochrome c (the third electron in the COX catalytic cycle) and protonation of the hydroxyl bound to CuB lead to the F state. The F state is homologous to compound II of peroxidases. In the heme-copper oxidases of the B family, only the intermediate state P was kinetically resolved [117]. The intermediate state F was observed only in stationary measurements during prolonged incubation with excess H2O2 (for details, see [118]). For the heme-copper oxidases of the C family, only computer calculations were reported. According to these calculations, the PM state is not energetically favorable and is not formed [119].
In addition to the main reaction, for COX from mitochondria, peroxidase-like and catalase-like activities were demonstrated. It was found that COX can catalyze the reduction of H2O2 in the presence of cytochrome c, i.e., cytochrome c peroxidase-like reaction [120]. The catalase-like activity (dismutation of H2O2) was observed initially by monitoring spectrophotometrically how the mitochondrial COX reduces the concentration of added H2O2 in the absence of an external electron donor [121]. This catalase-like activity of COX was described as dismutation of H2O2 with a turnover number of about 100 min−1. Recently, a second-order rate constant of 60–200 M−1·s−1 for the catalase-like activity of the bovine COX was obtained in more accurate measurements using an H2O2-sensitive electrode [122,123].
In the course of the reaction with H2O2, the BNC of COX goes through the same intermediates (PM and F), which are resolved during the O2 reduction. The PM and F intermediates of the mitochondrial COX (with different relative ratios) can be obtained in a steady state in the presence of H2O2. The pre-steady state measurements showed that the interaction of the BNC with two H2O2 molecules leads to the sequential formation of PM and the reduction of PM to F by the second H2O2 molecule with the production of O2•− [124]. During the reaction of the mitochondrial COX with H2O2 at a high concentration, two molecules of H2O2 reduce the PM state formed upon the binding of the first H2O2 to heme a3. Two molecules of O2•− are formed in the BNC and undergo dismutation into the new H2O2 molecule [124]. At submillimolar concentrations of H2O2, its decomposition occurs at least at two sites: (i) the catalytic heme a3−CuB center where H2O2 is reduced to water via the PM and F states, and (ii) the surface-exposed lipid-based radicals generated due to the migration of radicals formed initially in the catalytic heme a3−CuB center [125].
The mitochondrial COX can oxidize various aromatic compounds including some pharmacologically and physiologically active substances via the peroxidase mechanism [122]. Noticeably, the rates of both catalase-like and peroxidase-like activities of the mitochondrial COX are several orders of magnitude less than those for the true catalases and specific peroxidases (107 M−1·s−1). Hence, against the background of the specialized enzymes designed to scavenge ROS, the “parasitic” reactions (peroxidase-like and catalase-like activities) of the mitochondrial COX can be characterized as side reactions. For this reason, they are unlikely to be of physiological significance in the ROS detoxification in mitochondria. However, COX is present at a high concentration in all tissues in the body, and often there are tissues, such as the myocardium, in which there is no peroxidase at all against the background of large numbers of mitochondria. Additionally, specific localization of the enzyme in the mitochondrial membrane promotes the accumulation of hydrophobic aromatic substances. Thus, the nonspecific peroxidation catalyzed by COX via the peroxidase mechanism should be taken into account in some cases (e.g., metabolism of hydrophobic medicinal or cardiotoxic compounds) [122]. It should be noted that cytochrome c, which possesses peroxidase-like activity, could protect against ROS production in mitochondria [126].
Even though in mitochondria the function of direct ROS detoxification, a kind of “manual” work, is performed very effectively by specialized enzymes (peroxidases, catalases, superoxide dismutase, and glutathione reductases), COX nevertheless participates in the control of ROS but at a higher level of organization, through an indirect mechanism of ROS regulation in which COX performs signaling, rather than a catalytic function. The mechanism of reversible “allosteric ATP-inhibition” of dimeric COX keeps the ROS production and heat generation low in mitochondria by maintaining low values for the mitochondrial inner membrane potential [127]. This ability of COX to prevent oxygen radical formation and cellular damage is canceled by increased intracellular calcium, as a consequence of stress, which dephosphorylates and monomerizes COX.
The decomposition of H2O2 by the prokaryotic aa3-type cytochrome c oxidases from Rhodobacter sphaeroides and Paracoccus denitrificans (homologous to the mitochondrial COX) occurs at a rate of ten or more times faster as compared to the enzyme from mitochondria (up to 2800 and 3300 M−1·s−1, respectively) [122,128]. In contrast to the bovine enzyme, the observed rate of H2O2 decomposition by the bacterial COXs is too high to be explained by the catalytic cleavage of H2O2 in the oxygen reducing center, since the rate of H2O2 binding to the BNC is significantly smaller (500–800 M−1·s−1) than the catalase-like activity. This may indicate the protective significance of these “parasitic” reactions in bacteria. There is reason to believe that the Mg ion located in the A family COXs near the proposed proton-releasing pathways (for references, see [129]) can be replaced by the Mn ion, depending on the environment in which the bacteria exist, and this ion can perform a catalytic function [122]. Meanwhile, the Mn ions are known to be part of the catalytic center of peroxidases and very good catalysts for the peroxidase reaction.
It is known that inhibition of mitochondrial respiration by NO (targeting COX) and its derivatives stimulates ROS and RNS production by mitochondria, which have signaling roles in the heart but may also contribute to cell death [130]. In contrast to the A family mitochondrial COX, which is inhibited by NO, the NO reductase activity is observed for the B family heme-copper oxidases, e.g., the ba3 oxidase from Thermus thermophilus [131]. It is suggested that this activity may be related to the higher CuB affinity of these enzymes for gaseous ligands. It is known that the activity of NO reductase, an enzyme related to heme-copper oxidases, provides resistance of some bacteria to the immune response of macrophages [132]. The presence of the NO reductase activity in prokaryotic heme-copper oxidases may provide pathogenic bacteria with the antioxidant capacity to protect against ROS and RNS in the course of an immune response and develop resistance against these harmful species.
Finally, in bacteria, the heme-copper oxidases of the C family (cbb3-type enzymes), which are expressed in low-oxygen environments, can also perform a protective function against ROS, and are in some cases very effective. The high O2 affinity cytochrome cbb3, along with the bd oxidase, plays an important role in the protection of O2-sensitive nitrogenase in A. caulinodans by quickly consuming O2. The A. caulinodans mutant strain devoid of both terminal oxidases is no longer capable of fixing N2 [84]. Akin to cytochrome bd, the cbb3-type oxidase is necessary to reduce the environmental O2 pressure before anaerobic photosynthesis. Accordingly, in contrast to the wild-type R. gelatinosus strain, the double mutant lacking both cbb3 and bd oxidases can initiate photosynthesis only in a deoxygenated medium [90]. The C family heme-copper oxidases have been much less studied than the oxidases of the other families. For the oxidases of the B and C families, variability in the stoichiometry of proton pumping was reported. How this could be related/correlated to their activity to be expressed under low O2 conditions, as well as to the ability to suppress ROS, remains to be elucidated.

7. Concluding Remarks

Bacteria have evolved elaborate strategies to defend themselves from ROS and minimize oxidative damage. Many specialized detoxifying enzymes, such as superoxide dismutases, catalases, and peroxidases, have been extensively characterized. In this review, according to recent data, we report that terminal oxidases in bacterial respiratory chains may also play a protective role against ROS (Figure 8). Being efficient O2 scavengers, both copper-lacking cytochrome bd and the heme-copper oxidase cbb3 protect nitrogenase, the O2-labile enzyme complex responsible for catalyzing N2 fixation, from inactivation by O2, as documented in A. caulinodans, A. vinelandii, and K. pneumoniae. The bd and cbb3 oxidases also reduce the environmental O2 pressure, thereby expanding the physiological range of O2 tensions for the anoxygenic phototroph R. gelatinosus, which allows photosynthesis to start. The bd-type enzyme gives B. fragilis and D. gigas, classified as strict anaerobes, the ability to survive in low-oxygen environments. Furthermore, the E. coli cytochrome bd-I pulls electrons away from ROS-producing fumarate reductase, which leads to a reduced amount of ROS. Finally, cytochrome bd-I and cytochrome bd-II from E. coli may directly metabolize H2O2 through the catalase mechanism. The former cytochrome can apparently catalyze ROS removal through another mechanism as well, acting as a quinol peroxidase.
These relevant features of bacterial terminal oxidases may provide opportunities for biotechnological applications aimed at increasing O2 and ROS resistance in microbes and open up an attractive area of study for the development of novel antimicrobials to fight the increasingly serious threat of antibiotic resistance in pathogenic microorganisms.

Author Contributions

V.B.B., S.A.S. and E.F. performed the literature review and drafted the paper; V.B.B. and E.F. conceived and performed experiments on bd-II; M.R.N. assisted in the evaluation of the literature and finalized the manuscript for submission. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Russian Foundation for Basic Research—research project number 19-04-00094 (to V.B.B.) and by Sapienza grant number RP120172B8B36A98 (to E.F.).

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Abbreviations

BNCbinuclear center
COcarbon monoxide
COXcytochrome c oxidase
dQH2decyl-ubiquinol
DTTdithiothreitol
HQNO2-n-heptyl 4-hydroxyquinoline-N-oxide
NOnitric oxide
Q12,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone

References

  1. Mourenza, A.; Gil, J.A.; Mateos, L.M.; Letek, M. Oxidative stress-generating antimicrobials, a novel strategy to overcome antibacterial resistance. Antioxidants 2020, 9, 361. [Google Scholar] [CrossRef] [PubMed]
  2. Jakubovics, N.S.; Gill, S.R.; Vickerman, M.M.; Kolenbrander, P.E. Role of hydrogen peroxide in competition and cooperation between Streptococcus gordonii and Actinomyces naeslundii. FEMS Microbiol. Ecol. 2008, 66, 637–644. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Seaver, L.C.; Imlay, J.A. Are respiratory enzymes the primary sources of intracellular hydrogen peroxide? J. Biol. Chem. 2004, 279, 48742–48750. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Vatansever, F.; de Melo, W.C.; Avci, P.; Vecchio, D.; Sadasivam, M.; Gupta, A.; Chandran, R.; Karimi, M.; Parizotto, N.A.; Yin, R.; et al. Antimicrobial strategies centered around reactive oxygen species—Bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol. Rev. 2013, 37, 955–989. [Google Scholar] [CrossRef] [Green Version]
  5. Johnson, L.A.; Hug, L.A. Distribution of reactive oxygen species defense mechanisms across domain bacteria. Free Radic. Biol. Med. 2019, 140, 93–102. [Google Scholar] [CrossRef] [PubMed]
  6. Loewen, P.C.; Switala, J.; Triggs-Raine, B.L. Catalases HPI and HPII in Escherichia coli are induced independently. Arch. Biochem. Biophys. 1985, 243, 144–149. [Google Scholar] [CrossRef]
  7. Imlay, J.A. Cellular defenses against superoxide and hydrogen peroxide. Annu. Rev. Biochem. 2008, 77, 755–776. [Google Scholar] [CrossRef] [Green Version]
  8. Khademian, M.; Imlay, J.A. Escherichia coli cytochrome c peroxidase is a respiratory oxidase that enables the use of hydrogen peroxide as a terminal electron acceptor. Proc. Natl. Acad. Sci. USA 2017, 114, E6922–E6931. [Google Scholar] [CrossRef] [Green Version]
  9. Nobrega, C.S.; Devreese, B.; Pauleta, S.R. YhjA—An Escherichia coli trihemic enzyme with quinol peroxidase activity. Biochim. Biophys. Acta Bioenerg. 2018, 1859, 411–422. [Google Scholar] [CrossRef]
  10. Malatesta, F.; Antonini, G.; Sarti, P.; Brunori, M. Structure and Function of a Molecular Machine: Cytochrome c Oxidase. Biophys. Chem. 1995, 54, 1–33. [Google Scholar] [CrossRef]
  11. Melo, A.M.; Teixeira, M. Supramolecular organization of bacterial aerobic respiratory chains: From cells and back. Biochim. Biophys. Acta 2016, 1857, 190–197. [Google Scholar] [CrossRef] [PubMed]
  12. Pereira, M.M.; Sousa, F.L.; Verissimo, A.F.; Teixeira, M. Looking for the minimum common denominator in haem-copper oxygen reductases: Towards a unified catalytic mechanism. Biochim. Biophys. Acta 2008, 1777, 929–934. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Papa, S.; Capitanio, N.; Capitanio, G.; Palese, L.L. Protonmotive cooperativity in cytochrome c oxidase. Biochim. Biophys. Acta 2004, 1658, 95–105. [Google Scholar] [CrossRef] [Green Version]
  14. Borisov, V.B.; Siletsky, S.A. Features of organization and mechanism of catalysis of two families of terminal oxidases: Heme-copper and bd-type. Biochemistry 2019, 84, 1390–1402. [Google Scholar] [CrossRef]
  15. Hederstedt, L. Molecular biology of Bacillus subtilis cytochromes anno 2020. Biochemistry 2021, 86, 8–21. [Google Scholar] [CrossRef]
  16. Sousa, F.L.; Alves, R.J.; Ribeiro, M.A.; Pereira-Leal, J.B.; Teixeira, M.; Pereira, M.M. The superfamily of heme-copper oxygen reductases: Types and evolutionary considerations. Biochim. Biophys. Acta 2012, 1817, 629–637. [Google Scholar] [CrossRef] [Green Version]
  17. Wikstrom, M.; Krab, K.; Sharma, V. Oxygen activation and energy conservation by cytochrome c oxidase. Chem. Rev. 2018, 118, 2469–2490. [Google Scholar] [CrossRef] [Green Version]
  18. Capitanio, N.; Palese, L.L.; Capitanio, G.; Martino, P.L.; Richter, O.M.; Ludwig, B.; Papa, S. Allosteric interactions and proton conducting pathways in proton pumping aa3 oxidases: Heme a as a key coupling element. Biochim. Biophys. Acta 2012, 1817, 558–566. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Maneg, O.; Malatesta, F.; Ludwig, B.; Drosou, V. Interaction of cytochrome c with cytochrome oxidase: Two different docking scenarios. Biochim. Biophys. Acta 2004, 1655, 274–281. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Von Ballmoos, C.; Adelroth, P.; Gennis, R.B.; Brzezinski, P. Proton transfer in ba3 cytochrome c oxidase from Thermus thermophilus. Biochim. Biophys. Acta 2012, 1817, 650–657. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Rich, P.R. Mitochondrial cytochrome c oxidase: Catalysis, coupling and controversies. Biochem. Soc. Trans. 2017, 45, 813–829. [Google Scholar] [CrossRef] [PubMed]
  22. Yoshikawa, S.; Shimada, A. Reaction mechanism of cytochrome c oxidase. Chem. Rev. 2015, 115, 1936–1989. [Google Scholar] [CrossRef] [PubMed]
  23. Siletsky, S.A. Steps of the coupled charge translocation in the catalytic cycle of cytochrome c oxidase. Front. Biosci. 2013, 18, 36–57. [Google Scholar] [CrossRef] [PubMed]
  24. Forte, E.; Giuffre, A.; Huang, L.S.; Berry, E.A.; Borisov, V.B. Nitric oxide does not inhibit but is metabolized by the cytochrome bcc-aa3 supercomplex. Int. J. Mol. Sci. 2020, 21, 8521. [Google Scholar] [CrossRef]
  25. Poole, R.K.; Cook, G.M. Redundancy of aerobic respiratory chains in bacteria? Routes, reasons and regulation. Adv. Microb. Physiol. 2000, 43, 165–224. [Google Scholar] [CrossRef] [PubMed]
  26. Ingledew, W.J.; Poole, R.K. The respiratory chains of Escherichia coli. Microbiol. Rev. 1984, 48, 222–271. [Google Scholar] [CrossRef]
  27. Safarian, S.; Rajendran, C.; Muller, H.; Preu, J.; Langer, J.D.; Ovchinnikov, S.; Hirose, T.; Kusumoto, T.; Sakamoto, J.; Michel, H. Structure of a bd oxidase indicates similar mechanisms for membrane-integrated oxygen reductases. Science 2016, 352, 583–586. [Google Scholar] [CrossRef] [Green Version]
  28. Safarian, S.; Hahn, A.; Mills, D.J.; Radloff, M.; Eisinger, M.L.; Nikolaev, A.; Meier-Credo, J.; Melin, F.; Miyoshi, H.; Gennis, R.B.; et al. Active site rearrangement and structural divergence in prokaryotic respiratory oxidases. Science 2019, 366, 100–104. [Google Scholar] [CrossRef]
  29. Theßeling, A.; Rasmussen, T.; Burschel, S.; Wohlwend, D.; Kagi, J.; Muller, R.; Bottcher, B.; Friedrich, T. Homologous bd oxidases share the same architecture but differ in mechanism. Nat. Commun. 2019, 10, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Puustinen, A.; Finel, M.; Haltia, T.; Gennis, R.B.; Wikstrom, M. Properties of the two terminal oxidases of Escherichia coli. Biochemistry 1991, 30, 3936–3942. [Google Scholar] [CrossRef] [PubMed]
  31. Jasaitis, A.; Borisov, V.B.; Belevich, N.P.; Morgan, J.E.; Konstantinov, A.A.; Verkhovsky, M.I. Electrogenic reactions of cytochrome bd. Biochemistry 2000, 39, 13800–13809. [Google Scholar] [CrossRef] [PubMed]
  32. Siletsky, S.A.; Borisov, V.B.; Mamedov, M.D. Photosystem II and terminal respiratory oxidases: Molecular machines operating in opposite directions. Front. Biosci. 2017, 22, 1379–1426. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Belevich, I.; Borisov, V.B.; Zhang, J.; Yang, K.; Konstantinov, A.A.; Gennis, R.B.; Verkhovsky, M.I. Time-resolved electrometric and optical studies on cytochrome bd suggest a mechanism of electron-proton coupling in the di-heme active site. Proc. Natl. Acad. Sci. USA 2005, 102, 3657–3662. [Google Scholar] [CrossRef] [Green Version]
  34. Belevich, I.; Borisov, V.B.; Verkhovsky, M.I. Discovery of the true peroxy intermediate in the catalytic cycle of terminal oxidases by real-time measurement. J. Biol. Chem. 2007, 282, 28514–28519. [Google Scholar] [CrossRef] [Green Version]
  35. Borisov, V.B.; Belevich, I.; Bloch, D.A.; Mogi, T.; Verkhovsky, M.I. Glutamate 107 in subunit I of cytochrome bd from Escherichia coli is part of a transmembrane intraprotein pathway conducting protons from the cytoplasm to the heme b595/heme d active site. Biochemistry 2008, 47, 7907–7914. [Google Scholar] [CrossRef] [PubMed]
  36. Wikstrom, M.; Morgan, J.E.; Verkhovsky, M.I. Proton and electrical charge translocation by cytochrome c-oxidase. Biochim. Biophys. Acta 1997, 1318, 299–306. [Google Scholar] [CrossRef] [Green Version]
  37. Konstantinov, A.A.; Siletsky, S.; Mitchell, D.; Kaulen, A.; Gennis, R.B. The roles of the two proton input channels in cytochrome c oxidase from Rhodobacter sphaeroides probed by the effects of site-directed mutations on time-resolved electrogenic intraprotein proton transfer. Proc. Natl. Acad. Sci. USA 1997, 94, 9085–9090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Borisov, V.B.; Murali, R.; Verkhovskaya, M.L.; Bloch, D.A.; Han, H.; Gennis, R.B.; Verkhovsky, M.I. Aerobic respiratory chain of Escherichia coli is not allowed to work in fully uncoupled mode. Proc. Natl. Acad. Sci. USA 2011, 108, 17320–17324. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Pereira, M.M.; Santana, M.; Teixeira, M. A novel scenario for the evolution of haem-copper oxygen reductases. Biochim. Biophys. Acta 2001, 1505, 185–208. [Google Scholar] [CrossRef] [Green Version]
  40. Pereira, M.M.; Gomes, C.M.; Teixeira, M. Plasticity of proton pathways in haem-copper oxygen reductases. FEBS Lett. 2002, 522, 14–18. [Google Scholar] [CrossRef] [Green Version]
  41. Pereira, M.M.; Teixeira, M. Proton pathways, ligand binding and dynamics of the catalytic site in haem-copper oxygen reductases: A comparison between the three families. Biochim. Biophys. Acta 2004, 1655, 340–346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Borisov, V.B.; Gennis, R.B.; Hemp, J.; Verkhovsky, M.I. The cytochrome bd respiratory oxygen reductases. Biochim. Biophys. Acta 2011, 1807, 1398–1413. [Google Scholar] [CrossRef] [Green Version]
  43. Arutyunyan, A.M.; Sakamoto, J.; Inadome, M.; Kabashima, Y.; Borisov, V.B. Optical and magneto-optical activity of cytochrome bd from Geobacillus thermodenitrificans. Biochim. Biophys. Acta 2012, 1817, 2087–2094. [Google Scholar] [CrossRef] [Green Version]
  44. Srinivasan, V.; Rajendran, C.; Sousa, F.L.; Melo, A.M.; Saraiva, L.M.; Pereira, M.M.; Santana, M.; Teixeira, M.; Michel, H. Structure at 1.3 A resolution of Rhodothermus marinus caa3 cytochrome c domain. J. Mol. Biol. 2005, 345, 1047–1057. [Google Scholar] [CrossRef]
  45. Buschmann, S.; Warkentin, E.; Xie, H.; Langer, J.D.; Ermler, U.; Michel, H. The structure of cbb3 cytochrome oxidase provides insights into proton pumping. Science 2010, 329, 327–330. [Google Scholar] [CrossRef]
  46. Noor, M.R.; Soulimane, T. Structure of caa3 cytochrome c oxidase—A nature-made enzyme-substrate complex. Biol. Chem. 2013, 394, 579–591. [Google Scholar] [CrossRef]
  47. Azarkina, N.; Siletsky, S.; Borisov, V.; von Wachenfeldt, C.; Hederstedt, L.; Konstantinov, A.A. A cytochrome bb’-type quinol oxidase in Bacillus subtilis strain 168. J. Biol. Chem. 1999, 274, 32810–32817. [Google Scholar] [CrossRef] [Green Version]
  48. Verkhovsky, M.I.; Morgan, J.E.; Puustinen, A.; Wikstrom, M. Kinetic trapping of oxygen in cell respiration. Nature 1996, 380, 268–270. [Google Scholar] [CrossRef]
  49. D’mello, R.; Hill, S.; Poole, R.K. The cytochrome bd quinol oxidase in Escherichia coli has an extremely high oxygen affinity and two-oxygen-binding haems: Implicaitons for regulation of activity in vivo by oxygen inihibition. Microbiology 1996, 142, 755–763. [Google Scholar] [CrossRef] [Green Version]
  50. Belevich, I.; Borisov, V.B.; Konstantinov, A.A.; Verkhovsky, M.I. Oxygenated complex of cytochrome bd from Escherichia coli: Stability and photolability. FEBS Lett. 2005, 579, 4567–4570. [Google Scholar] [CrossRef] [Green Version]
  51. Belevich, I.; Borisov, V.B.; Bloch, D.A.; Konstantinov, A.A.; Verkhovsky, M.I. Cytochrome bd from Azotobacter vinelandii: Evidence for high-affinity oxygen binding. Biochemistry 2007, 46, 11177–11184. [Google Scholar] [CrossRef]
  52. Forte, E.; Borisov, V.B.; Konstantinov, A.A.; Brunori, M.; Giuffre, A.; Sarti, P. Cytochrome bd, a key oxidase in bacterial survival and tolerance to nitrosative stress. Ital. J. Biochem. 2007, 56, 265–269. [Google Scholar]
  53. Borisov, V.B.; Forte, E.; Siletsky, S.A.; Arese, M.; Davletshin, A.I.; Sarti, P.; Giuffre, A. Cytochrome bd protects bacteria against oxidative and nitrosative stress: A potential target for next-generation antimicrobial agents. Biochemistry 2015, 80, 565–575. [Google Scholar] [CrossRef]
  54. Giuffre, A.; Borisov, V.B.; Mastronicola, D.; Sarti, P.; Forte, E. Cytochrome bd oxidase and nitric oxide: From reaction mechanisms to bacterial physiology. FEBS Lett. 2012, 586, 622–629. [Google Scholar] [CrossRef]
  55. Giuffre, A.; Borisov, V.B.; Arese, M.; Sarti, P.; Forte, E. Cytochrome bd oxidase and bacterial tolerance to oxidative and nitrosative stress. Biochim. Biophys. Acta 2014, 1837, 1178–1187. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Forte, E.; Borisov, V.B.; Vicente, J.B.; Giuffre, A. Cytochrome bd and gaseous ligands in bacterial physiology. Adv. Microb. Physiol. 2017, 71, 171–234. [Google Scholar] [CrossRef] [PubMed]
  57. Borisov, V.B.; Forte, E.; Konstantinov, A.A.; Poole, R.K.; Sarti, P.; Giuffre, A. Interaction of the bacterial terminal oxidase cytochrome bd with nitric oxide. FEBS Lett. 2004, 576, 201–204. [Google Scholar] [CrossRef] [Green Version]
  58. Borisov, V.B.; Forte, E.; Sarti, P.; Brunori, M.; Konstantinov, A.A.; Giuffre, A. Nitric oxide reacts with the ferryl-oxo catalytic intermediate of the CuB-lacking cytochrome bd terminal oxidase. FEBS Lett. 2006, 580, 4823–4826. [Google Scholar] [CrossRef] [Green Version]
  59. Borisov, V.B.; Forte, E.; Sarti, P.; Brunori, M.; Konstantinov, A.A.; Giuffre, A. Redox control of fast ligand dissociation from Escherichia coli cytochrome bd. Biochem. Biophys. Res. Commun. 2007, 355, 97–102. [Google Scholar] [CrossRef]
  60. Mason, M.G.; Shepherd, M.; Nicholls, P.; Dobbin, P.S.; Dodsworth, K.S.; Poole, R.K.; Cooper, C.E. Cytochrome bd confers nitric oxide resistance to Escherichia coli. Nat. Chem. Biol. 2009, 5, 94–96. [Google Scholar] [CrossRef]
  61. Borisov, V.B.; Forte, E.; Giuffre, A.; Konstantinov, A.; Sarti, P. Reaction of nitric oxide with the oxidized di-heme and heme-copper oxygen-reducing centers of terminal oxidases: Different reaction pathways and end-products. J. Inorg. Biochem. 2009, 103, 1185–1187. [Google Scholar] [CrossRef]
  62. Shepherd, M.; Achard, M.E.; Idris, A.; Totsika, M.; Phan, M.D.; Peters, K.M.; Sarkar, S.; Ribeiro, C.A.; Holyoake, L.V.; Ladakis, D.; et al. The cytochrome bd-I respiratory oxidase augments survival of multidrug-resistant Escherichia coli during infection. Sci. Rep. 2016, 6, 35285. [Google Scholar] [CrossRef] [PubMed]
  63. Holyoake, L.V.; Hunt, S.; Sanguinetti, G.; Cook, G.M.; Howard, M.J.; Rowe, M.L.; Poole, R.K.; Shepherd, M. CydDC-mediated reductant export in Escherichia coli controls the transcriptional wiring of energy metabolism and combats nitrosative stress. Biochem. J. 2016, 473, 693–701. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Jones-Carson, J.; Husain, M.; Liu, L.; Orlicky, D.J.; Vazquez-Torres, A. Cytochrome bd-dependent bioenergetics and antinitrosative defenses in Salmonella pathogenesis. mBio 2016, 7, e02052–16. [Google Scholar] [CrossRef] [Green Version]
  65. Meng, Q.; Yin, J.; Jin, M.; Gao, H. Distinct nitrite and nitric oxide physiologies in Escherichia coli and Shewanella oneidensis. Appl. Environ. Microbiol. 2018, 84, e00559–18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Beebout, C.J.; Eberly, A.R.; Werby, S.H.; Reasoner, S.A.; Brannon, J.R.; De, S.; Fitzgerald, M.J.; Huggins, M.M.; Clayton, D.B.; Cegelski, L.; et al. Respiratory heterogeneity shapes biofilm formation and host colonization in uropathogenic Escherichia coli. mBio 2019, 10, e02400–18. [Google Scholar] [CrossRef] [Green Version]
  67. Borisov, V.B.; Forte, E.; Siletsky, S.A.; Sarti, P.; Giuffre, A. Cytochrome bd from Escherichia coli catalyzes peroxynitrite decomposition. Biochim. Biophys. Acta 2015, 1847, 182–188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Forte, E.; Borisov, V.B.; Falabella, M.; Colaco, H.G.; Tinajero-Trejo, M.; Poole, R.K.; Vicente, J.B.; Sarti, P.; Giuffre, A. The terminal oxidase cytochrome bd promotes sulfide-resistant bacterial respiration and growth. Sci. Rep. 2016, 6, 23788. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Korshunov, S.; Imlay, K.R.; Imlay, J.A. The cytochrome bd oxidase of Escherichia coli prevents respiratory inhibition by endogenous and exogenous hydrogen sulfide. Mol. Microbiol. 2016, 101, 62–77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Forte, E.; Giuffre, A. How bacteria breathe in hydrogen sulphide-rich environments. Biochemist 2016, 38, 8–11. [Google Scholar] [CrossRef]
  71. Borisov, V.B.; Forte, E. Terminal oxidase cytochrome bd protects bacteria against hydrogen sulfide toxicity. Biochemistry 2021, 86, 22–32. [Google Scholar] [CrossRef]
  72. Forte, E.; Siletsky, S.A.; Borisov, V.B. In Escherichia coli ammonia inhibits cytochrome bo3 but activates cytochrome bd-I. Antioxidants 2021, 10, 13. [Google Scholar] [CrossRef] [PubMed]
  73. Kita, K.; Konishi, K.; Anraku, Y. Terminal oxidases of Escherichia coli aerobic respiratory chain. II. Purification and properties of cytochrome b558-d complex from cells grown with limited oxygen and evidence of branched electron-carrying systems. J. Biol. Chem. 1984, 259, 3375–3381. [Google Scholar] [CrossRef]
  74. Sakamoto, J.; Koga, E.; Mizuta, T.; Sato, C.; Noguchi, S.; Sone, N. Gene structure and quinol oxidase activity of a cytochrome bd-type oxidase from Bacillus stearothermophilus. Biochim. Biophys. Acta 1999, 1411, 147–158. [Google Scholar] [CrossRef] [Green Version]
  75. Borisov, V.B.; Siletsky, S.A.; Paiardini, A.; Hoogewijs, D.; Forte, E.; Giuffre, A.; Poole, R.K. Bacterial oxidases of the cytochrome bd family: Redox enzymes of unique structure, function and utility as drug targets. Antioxid. Redox Signal. 2021, 34, 1280–1318. [Google Scholar] [CrossRef] [PubMed]
  76. Mascolo, L.; Bald, D. Cytochrome bd in Mycobacterium tuberculosis: A respiratory chain protein involved in the defense against antibacterials. Prog. Biophys. Mol. Biol. 2020, 152, 55–63. [Google Scholar] [CrossRef] [PubMed]
  77. Lee, B.S.; Sviriaeva, E.; Pethe, K. Targeting the cytochrome oxidases for drug development in mycobacteria. Prog. Biophys. Mol. Biol. 2020, 152, 45–54. [Google Scholar] [CrossRef] [PubMed]
  78. Cook, G.M.; Hards, K.; Dunn, E.; Heikal, A.; Nakatani, Y.; Greening, C.; Crick, D.C.; Fontes, F.L.; Pethe, K.; Hasenoehrl, E.; et al. Oxidative phosphorylation as a target space for tuberculosis: Success, caution, and future directions. Microbiol. Spectr. 2017, 5, 295–316. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Bald, D.; Villellas, C.; Lu, P.; Koul, A. Targeting energy metabolism in Mycobacterium tuberculosis, a new paradigm in antimycobacterial drug discovery. mBio 2017, 8, e00272–17. [Google Scholar] [CrossRef] [Green Version]
  80. Hards, K.; Cook, G.M. Targeting bacterial energetics to produce new antimicrobials. Drug Resist. Update 2018, 36, 1–12. [Google Scholar] [CrossRef] [PubMed]
  81. Winstedt, L.; Frankenberg, L.; Hederstedt, L.; von Wachenfeldt, C. Enterococcus faecalis V583 contains a cytochrome bd-type respiratory oxidase. J. Bacteriol. 2000, 182, 3863–3866. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Junemann, S.; Butterworth, P.J.; Wrigglesworth, J.M. A suggested mechanism for the catalytic cycle of cytochrome bd terminal oxidase based on kinetic analysis. Biochemistry 1995, 34, 14861–14867. [Google Scholar] [CrossRef] [PubMed]
  83. Poole, R.K.; Hill, S. Respiratory protection of nitrogenase activity in Azotobacter vinelandii—Roles of the terminal oxidases. Biosci. Rep. 1997, 17, 307–317. [Google Scholar] [CrossRef]
  84. Kaminski, P.A.; Kitts, C.L.; Zimmerman, Z.; Ludwig, R.A. Azorhizobium caulinodans uses both cytochrome bd (quinol) and cytochrome cbb3 (cytochrome c) terminal oxidases for symbiotic N2 fixation. J. Bacteriol. 1996, 178, 5989–5994. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Juty, N.S.; Moshiri, F.; Merrick, M.; Anthony, C.; Hill, S. The Klebsiella pneumoniae cytochrome bd’ terminal oxidase complex and its role in microaerobic nitrogen fixation. Microbiology 1997, 143, 2673–2683. [Google Scholar] [CrossRef] [Green Version]
  86. Kelly, M.J.S.; Poole, R.K.; Yates, M.G.; Kennedy, C. Cloning and mutagenesis of genes encoding the cytochrome bd terminal oxidase complex in Azotobacter vinelandii: Mutants deficient in the cytochrome d complex are unable to fix nitrogen in air. J. Bacteriol. 1990, 172, 6010–6019. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Baughn, A.D.; Malamy, M.H. The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen. Nature 2004, 427, 441–444. [Google Scholar] [CrossRef] [PubMed]
  88. Lemos, R.S.; Gomes, C.M.; Santana, M.; LeGall, J.; Xavier, A.V.; Teixeira, M. The ‘strict’ anaerobe Desulfovibrio gigas contains a membrane-bound oxygen-reducing respiratory chain. FEBS Lett. 2001, 496, 40–43. [Google Scholar] [CrossRef] [Green Version]
  89. Machado, P.; Felix, R.; Rodrigues, R.; Oliveira, S.; Rodrigues-Pousada, C. Characterization and expression analysis of the cytochrome bd oxidase operon from Desulfovibrio gigas. Curr. Microbiol. 2006, 52, 274–281. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  90. Hassani, B.K.; Steunou, A.S.; Liotenberg, S.; Reiss-Husson, F.; Astier, C.; Ouchane, S. Adaptation to oxygen: Role of terminal oxidases in photosynthesis initiation in the purple photosynthetic bacterium, Rubrivivax gelatinosus. J. Biol. Chem. 2010, 285, 19891–19899. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  91. Korshunov, S.; Imlay, J.A. Two sources of endogenous hydrogen peroxide in Escherichia coli. Mol. Microbiol. 2010, 75, 1389–1401. [Google Scholar] [CrossRef] [Green Version]
  92. Wall, D.; Delaney, J.M.; Fayet, O.; Lipinska, B.; Yamamoto, T.; Georgopoulos, C. arc-Dependent thermal regulation and extragenic suppression of the Escherichia coli cytochrome d operon. J. Bacteriol. 1992, 174, 6554–6562. [Google Scholar] [CrossRef] [Green Version]
  93. Goldman, B.S.; Gabbert, K.K.; Kranz, R.G. The temperature-sensitive growth and survival phenotypes of Escherichia coli cydDC and cydAB strains are due to deficiencies in cytochrome bd and are corrected by exogenous catalase and reducing agents. J. Bacteriol. 1996, 178, 6348–6351. [Google Scholar] [CrossRef] [Green Version]
  94. Lindqvist, A.; Membrillo-Hernandez, J.; Poole, R.K.; Cook, G.M. Roles of respiratory oxidases in protecting Escherichia coli K12 from oxidative stress. Antonie Leeuwenhoek 2000, 78, 23–31. [Google Scholar] [CrossRef] [PubMed]
  95. Edwards, S.E.; Loder, C.S.; Wu, G.; Corker, H.; Bainbridge, B.W.; Hill, S.; Poole, R.K. Mutation of cytochrome bd quinol oxidase results in reduced stationary phase survival, iron deprivation, metal toxicity and oxidative stress in Azotobacter vinelandii. FEMS Microbiol. Lett. 2000, 185, 71–77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Xia, X.; Wu, S.; Li, L.; Xu, B.; Wang, G. The cytochrome bd complex is essential for chromate and sulfide resistance and is regulated by a GbsR-type regulator, CydE, in Alishewanella sp. WH16-1. Front. Microbiol. 2018, 9, 1849. [Google Scholar] [CrossRef]
  97. Endley, S.; McMurray, D.; Ficht, T.A. Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection. J. Bacteriol. 2001, 183, 2454–2462. [Google Scholar] [CrossRef] [Green Version]
  98. Leclerc, J.; Rosenfeld, E.; Trainini, M.; Martin, B.; Meuric, V.; Bonnaure-Mallet, M.; Baysse, C. The cytochrome bd oxidase of Porphyromonas gingivalis contributes to oxidative stress resistance and dioxygen tolerance. PLoS ONE 2015, 10, e0143808. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Small, J.L.; Park, S.W.; Kana, B.D.; Ioerger, T.R.; Sacchettini, J.C.; Ehrt, S. Perturbation of cytochrome c maturation reveals adaptability of the respiratory chain in Mycobacterium tuberculosis. mBio 2013, 4, e00475–13. [Google Scholar] [CrossRef] [Green Version]
  100. Lu, P.; Heineke, M.H.; Koul, A.; Andries, K.; Cook, G.M.; Lill, H.; van Spanning, R.; Bald, D. The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress. Sci. Rep. 2015, 5, 10333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  101. Chang, W.; Small, D.A.; Toghrol, F.; Bentley, W.E. Global transcriptome analysis of Staphylococcus aureus response to hydrogen peroxide. J. Bacteriol. 2006, 188, 1648–1659. [Google Scholar] [CrossRef] [Green Version]
  102. Borisov, V.B.; Forte, E.; Davletshin, A.; Mastronicola, D.; Sarti, P.; Giuffre, A. Cytochrome bd oxidase from Escherichia coli displays high catalase activity: An additional defense against oxidative stress. FEBS Lett. 2013, 587, 2214–2218. [Google Scholar] [CrossRef] [PubMed]
  103. Brown, G.C. Reversible binding and inhibition of catalase by nitric oxide. Eur. J. Biochem. 1995, 232, 188–191. [Google Scholar] [CrossRef] [PubMed]
  104. Deisseroth, A.; Dounce, A.L. Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role. Physiol. Rev. 1970, 50, 319–375. [Google Scholar] [CrossRef] [PubMed]
  105. Su, S.; Panmanee, W.; Wilson, J.J.; Mahtani, H.K.; Li, Q.; Vanderwielen, B.D.; Makris, T.M.; Rogers, M.; McDaniel, C.; Lipscomb, J.D.; et al. Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa. PLoS ONE 2014, 9, e91813. [Google Scholar] [CrossRef]
  106. Al-Attar, S.; Yu, Y.; Pinkse, M.; Hoeser, J.; Friedrich, T.; Bald, D.; de Vries, S. Cytochrome bd displays significant quinol peroxidase activity. Sci. Rep. 2016, 6, 27631. [Google Scholar] [CrossRef] [Green Version]
  107. Meunier, B.; Madgwick, S.A.; Reil, E.; Oettmeier, W.; Rich, P.R. New inhibitors of the quinol oxidation sites of bacterial cytochromes bo and bd. Biochemistry 1995, 34, 1076–1083. [Google Scholar] [CrossRef]
  108. Reisz, J.A.; Bechtold, E.; King, S.B.; Poole, L.B.; Furdui, C.M. Thiol-blocking electrophiles interfere with labeling and detection of protein sulfenic acids. FEBS J. 2013, 280, 6150–6161. [Google Scholar] [CrossRef] [Green Version]
  109. Forte, E.; Borisov, V.B.; Siletsky, S.A.; Petrosino, M.; Giuffre, A. In the respiratory chain of Escherichia coli cytochromes bd-I and bd-II are more sensitive to carbon monoxide inhibition than cytochrome bo3. Biochim. Biophys. Acta Bioenerg. 2019, 1860, 148088. [Google Scholar] [CrossRef]
  110. Borisov, V.; Arutyunyan, A.M.; Osborne, J.P.; Gennis, R.B.; Konstantinov, A.A. Magnetic circular dichroism used to examine the interaction of Escherichia coli cytochrome bd with ligands. Biochemistry 1999, 38, 740–750. [Google Scholar] [CrossRef]
  111. Borisov, V.B. Effect of membrane environment on ligand-binding properties of the terminal oxidase cytochrome bd-I from Escherichia coli. Biochemistry 2020, 85, 1603–1612. [Google Scholar] [CrossRef]
  112. Chanin, R.B.; Winter, M.G.; Spiga, L.; Hughes, E.R.; Zhu, W.; Taylor, S.J.; Arenales, A.; Gillis, C.C.; Buttner, L.; Jimenez, A.G.; et al. Epithelial-derived reactive oxygen species enable AppBCX-mediated aerobic respiration of Escherichia coli during intestinal inflammation. Cell Host Microbe 2020, 28, 780–788. [Google Scholar] [CrossRef] [PubMed]
  113. Forte, E.; Borisov, V.B.; Davletshin, A.; Mastronicola, D.; Sarti, P.; Giuffre, A. Cytochrome bd oxidase and hydrogen peroxide resistance in Mycobacterium tuberculosis. mBio 2013, 4, e01006–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. Borisov, V.B.; Davletshin, A.I.; Konstantinov, A.A. Peroxidase activity of cytochrome bd from Escherichia coli. Biochemistry 2010, 75, 428–436. [Google Scholar] [CrossRef] [PubMed]
  115. Siletsky, S.A.; Konstantinov, A.A. Cytochrome c oxidase: Charge translocation coupled to single-electron partial steps of the catalytic cycle. Biochim. Biophys. Acta 2012, 1817, 476–488. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  116. Kaila, V.R.I.; Wikstrom, M. Architecture of bacterial respiratory chains. Nat. Rev. Microbiol. 2021, 19, 319–330. [Google Scholar] [CrossRef]
  117. Siletsky, S.A.; Belevich, I.; Jasaitis, A.; Konstantinov, A.A.; Wikstrom, M.; Soulimane, T.; Verkhovsky, M.I. Time-resolved single-turnover of ba3 oxidase from Thermus thermophilus. Biochim. Biophys. Acta 2007, 1767, 1383–1392. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  118. Siletskiy, S.; Soulimane, T.; Azarkina, N.; Vygodina, T.V.; Buse, G.; Kaulen, A.; Konstantinov, A. Time-resolved generation of a membrane potential by ba3 cytochrome c oxidase from Thermus thermophilus. Evidence for reduction-induced opening of the binuclear center. FEBS Lett. 1999, 457, 98–102. [Google Scholar] [CrossRef] [Green Version]
  119. Blomberg, M.R.A. Role of the two metals in the active sites of heme copper oxidases-A study of NO reduction in cbb3 cytochrome c oxidase. Inorg. Chem. 2020, 59, 11542–11553. [Google Scholar] [CrossRef]
  120. Orii, Y. The cytochrome c peroxidase activity of cytochrome oxidase. J. Biol. Chem. 1982, 257, 9246–9248. [Google Scholar] [CrossRef]
  121. Orii, Y.; Okunuki, K. Studies on cytochrome a. X. Effect of hydrogen peroxide on absorption spectra of cytochrome a. J. Biochem. 1963, 54, 207–213. [Google Scholar] [CrossRef] [PubMed]
  122. Bolshakov, I.A.; Vygodina, T.V.; Gennis, R.; Karyakin, A.A.; Konstantinov, A.A. Catalase activity of cytochrome c oxidase assayed with hydrogen peroxide-sensitive electrode microsensor. Biochemistry 2010, 75, 1352–1360. [Google Scholar] [CrossRef] [PubMed]
  123. Sedlak, E.; Fabian, M.; Robinson, N.C.; Musatov, A. Ferricytochrome c protects mitochondrial cytochrome c oxidase against hydrogen peroxide-induced oxidative damage. Free Radic. Biol. Med. 2010, 49, 1574–1581. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Ksenzenko, M.Y.; Berka, V.; Vygodina, T.V.; Ruuge, E.K.; Konstantinov, A.A. Cytochrome oxidase-catalyzed superoxide generation from hydrogen peroxide. FEBS Lett. 1992, 297, 63–66. [Google Scholar] [CrossRef] [Green Version]
  125. Jancura, D.; Stanicova, J.; Palmer, G.; Fabian, M. How hydrogen peroxide is metabolized by oxidized cytochrome c oxidase. Biochemistry 2014, 53, 3564–3575. [Google Scholar] [CrossRef]
  126. Pereverzev, M.O.; Vygodina, T.V.; Konstantinov, A.A.; Skulachev, V.P. Cytochrome c, an ideal antioxidant. Biochem. Soc. Trans. 2003, 31, 1312–1315. [Google Scholar] [CrossRef]
  127. Ramzan, R.; Rhiel, A.; Weber, P.; Kadenbach, B.; Vogt, S. Reversible dimerization of cytochrome c oxidase regulates mitochondrial respiration. Mitochondrion 2019, 49, 149–155. [Google Scholar] [CrossRef] [PubMed]
  128. Hilbers, F.; von der Hocht, I.; Ludwig, B.; Michel, H. True wild type and recombinant wild type cytochrome c oxidase from Paracoccus denitrificans show a 20-fold difference in their catalase activity. Biochim. Biophys. Acta 2013, 1827, 319–327. [Google Scholar] [CrossRef] [Green Version]
  129. Siletsky, S.A.; Gennis, R.B. Time-resolved electrometric study of the F→O transition in cytochrome c oxidase. The effect of Zn2+ ions on the positive side of the membrane. Biochemistry 2021, 86, 105–122. [Google Scholar] [CrossRef] [PubMed]
  130. Brown, G.C. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 2007, 35, 1119–1121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  131. Giuffre, A.; Stubauer, G.; Sarti, P.; Brunori, M.; Zumft, W.G.; Buse, G.; Soulimane, T. The heme-copper oxidases of Thermus thermophilus catalyze the reduction of nitric oxide: Evolutionary implications. Proc. Natl. Acad. Sci. USA 1999, 96, 14718–14723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  132. Hayashi, T.; Lin, I.J.; Chen, Y.; Fee, J.A.; Moenne-Loccoz, P. Fourier transform infrared characterization of a CuB-nitrosyl complex in cytochrome ba3 from Thermus thermophilus: Relevance to NO reductase activity in heme-copper terminal oxidases. J. Am. Chem. Soc. 2007, 129, 14952–14958. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Antioxidants 10 00839 g001 550
Figure 1. Cytochrome bd and cytochrome cbb3 protect O2-labile nitrogenase from oxidative inactivation.
Figure 1. Cytochrome bd and cytochrome cbb3 protect O2-labile nitrogenase from oxidative inactivation.
Antioxidants 10 00839 g001
Antioxidants 10 00839 g002 550
Figure 2. Catalase-like activity of the isolated as-prepared cytochrome bd-I from Escherichia coli (E. coli). Main panel: O2 formation induced by addition of 0.1 mM H2O2 to the oxidase. Inset: Dependence of the rate of O2 formation on H2O2 concentration. Adapted from [102].
Figure 2. Catalase-like activity of the isolated as-prepared cytochrome bd-I from Escherichia coli (E. coli). Main panel: O2 formation induced by addition of 0.1 mM H2O2 to the oxidase. Inset: Dependence of the rate of O2 formation on H2O2 concentration. Adapted from [102].
Antioxidants 10 00839 g002
Antioxidants 10 00839 g003 550
Figure 3. Catalase-like activity of catalase-deficient E. coli UM2 cells overexpressing cytochrome bd-I. Shown is the change in O2 concentration after the addition of 0.235 mM H2O2 to respiring cells in which the enzyme is either overexpressed (+pTK1 plasmid that carries the cydAB operon) or not (−pTK1 plasmid). Adapted from [102].
Figure 3. Catalase-like activity of catalase-deficient E. coli UM2 cells overexpressing cytochrome bd-I. Shown is the change in O2 concentration after the addition of 0.235 mM H2O2 to respiring cells in which the enzyme is either overexpressed (+pTK1 plasmid that carries the cydAB operon) or not (−pTK1 plasmid). Adapted from [102].
Antioxidants 10 00839 g003
Antioxidants 10 00839 g004 550
Figure 4. Proposed catalase-like activity of cytochrome bd-I and cytochrome bd-II from E. coli. Shown is the scheme for bd-type enzyme arrangement in the E. coli membrane bilayer based on the solved bd-I structure [28,29]. The oxidase consists of four different subunits, CydA, CydB, CydX, and CydH. CydA carries three hemes, b558, b595, and d.
Figure 4. Proposed catalase-like activity of cytochrome bd-I and cytochrome bd-II from E. coli. Shown is the scheme for bd-type enzyme arrangement in the E. coli membrane bilayer based on the solved bd-I structure [28,29]. The oxidase consists of four different subunits, CydA, CydB, CydX, and CydH. CydA carries three hemes, b558, b595, and d.
Antioxidants 10 00839 g004
Antioxidants 10 00839 g005 550
Figure 5. Catalase-like activity of the isolated cytochrome bd-II from E. coli. Top panel: The addition of 20 µM NO does not affect О2 evolution induced by the addition of 0.2 mM H2O2 to the as-prepared enzyme (50 nM). Bottom panel: О2 evolution is lacking if, before the addition of 1.32 mM H2O2, all O2 is consumed and cytochrome bd-II (12.8 nM) is converted into the fully reduced state by 10 mM DTT and 250 µM Q1. Subsequent addition of bona fide bovine catalase (2 µg/ml) restores the reaction. Cytochrome bd-II was isolated from E. coli strain MB37 as described [38]. Changes in O2 concentration were recorded using a high-resolution respirometer (Oxygraph-2k, Oroboros Instruments). Assays were performed at 25 °C in 50 mM Na/phosphate buffer (pH 7.0) containing 0.1 mM ethylenediaminetetraacetate (EDTA), supplemented with 0.02% dodecyl-β-D-maltoside.
Figure 5. Catalase-like activity of the isolated cytochrome bd-II from E. coli. Top panel: The addition of 20 µM NO does not affect О2 evolution induced by the addition of 0.2 mM H2O2 to the as-prepared enzyme (50 nM). Bottom panel: О2 evolution is lacking if, before the addition of 1.32 mM H2O2, all O2 is consumed and cytochrome bd-II (12.8 nM) is converted into the fully reduced state by 10 mM DTT and 250 µM Q1. Subsequent addition of bona fide bovine catalase (2 µg/ml) restores the reaction. Cytochrome bd-II was isolated from E. coli strain MB37 as described [38]. Changes in O2 concentration were recorded using a high-resolution respirometer (Oxygraph-2k, Oroboros Instruments). Assays were performed at 25 °C in 50 mM Na/phosphate buffer (pH 7.0) containing 0.1 mM ethylenediaminetetraacetate (EDTA), supplemented with 0.02% dodecyl-β-D-maltoside.
Antioxidants 10 00839 g005
Antioxidants 10 00839 g006 550
Figure 6. Inhibition of decyl-ubiquinol (dQH2) peroxidase activity of the isolated cytochrome bd-I from E. coli by NO. The reaction is monitored spectrophotometrically under anaerobic conditions. The addition of 6 μM NO promptly inhibits the enzymatic oxidation of 0.2 mM dQH2 by 10 mM H2O2. The inhibition is reversible as the activity gradually resumes due to the disappearance of NO. The latter is probably due to the reaction between NO and dQH2. Reprinted from [106].
Figure 6. Inhibition of decyl-ubiquinol (dQH2) peroxidase activity of the isolated cytochrome bd-I from E. coli by NO. The reaction is monitored spectrophotometrically under anaerobic conditions. The addition of 6 μM NO promptly inhibits the enzymatic oxidation of 0.2 mM dQH2 by 10 mM H2O2. The inhibition is reversible as the activity gradually resumes due to the disappearance of NO. The latter is probably due to the reaction between NO and dQH2. Reprinted from [106].
Antioxidants 10 00839 g006
Antioxidants 10 00839 g007 550
Figure 7. Proposed peroxidase-like activity of cytochrome bd-I from E. coli. Shown is the scheme for the enzyme arrangement in the E. coli membrane bilayer based on the solved bd-I structure [28,29]. The oxidase consists of four different subunits, CydA, CydB, CydX, and CydH. CydA carries three hemes (b558, b595, d) and the quinol binding site at which the electron donor dQH2) is likely bound.
Figure 7. Proposed peroxidase-like activity of cytochrome bd-I from E. coli. Shown is the scheme for the enzyme arrangement in the E. coli membrane bilayer based on the solved bd-I structure [28,29]. The oxidase consists of four different subunits, CydA, CydB, CydX, and CydH. CydA carries three hemes (b558, b595, d) and the quinol binding site at which the electron donor dQH2) is likely bound.
Antioxidants 10 00839 g007
Antioxidants 10 00839 g008 550
Figure 8. Overview of the proposed contribution of terminal oxidases to ROS defense mechanisms in bacteria.
Figure 8. Overview of the proposed contribution of terminal oxidases to ROS defense mechanisms in bacteria.
Antioxidants 10 00839 g008
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Borisov, V.B.; Siletsky, S.A.; Nastasi, M.R.; Forte, E. ROS Defense Systems and Terminal Oxidases in Bacteria. Antioxidants 2021, 10, 839. https://doi.org/10.3390/antiox10060839

AMA Style

Borisov VB, Siletsky SA, Nastasi MR, Forte E. ROS Defense Systems and Terminal Oxidases in Bacteria. Antioxidants. 2021; 10(6):839. https://doi.org/10.3390/antiox10060839

Chicago/Turabian Style

Borisov, Vitaliy B., Sergey A. Siletsky, Martina R. Nastasi, and Elena Forte. 2021. "ROS Defense Systems and Terminal Oxidases in Bacteria" Antioxidants 10, no. 6: 839. https://doi.org/10.3390/antiox10060839

APA Style

Borisov, V. B., Siletsky, S. A., Nastasi, M. R., & Forte, E. (2021). ROS Defense Systems and Terminal Oxidases in Bacteria. Antioxidants, 10(6), 839. https://doi.org/10.3390/antiox10060839

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop